Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate

Ann Oncol. 2017 Mar 1;28(3):668. doi: 10.1093/annonc/mdw674.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Abiraterone Acetate*
  • Docetaxel
  • Humans
  • Male
  • Prednisone*
  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Taxoids

Substances

  • Taxoids
  • Docetaxel
  • cabazitaxel
  • Abiraterone Acetate
  • Prednisone